There is still significant unmet need within select cardiovascular/metabolic (CVM) disorders. Unfortunately, the cost of developing drugs and devices in this area has been rising steadily. TCR, a full service provider, takes a data-driven approach to developing strategies that will cut timelines and costs. From First-in-Human (FIH) studies through post approval. We have experience conducting cardiovascular trials, with particular emphasis on cardiovascular/metabolic indications: heart failure, lipid disorders, diabetes, renal insufficiency and renal transplant, arrhythmia, medical devices and rare diseases.

What Our Clients Say

Find out how our research experts can help with your next study or program.